IMCT-08ReACT: LONG-TERM SURVIVAL FROM a RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
Journal article published in 2015 by
David A. Reardon,
Annick Desjardins,
James Schuster,
David D. Tran,
Karen L. Fink,
Louis B. Nabors,
Gordon Li,
Daniela A. Bota 
,
Rimas V. Lukas,
Lynn S. Ashby,
J. Paul Duic,
Maciej M. Mrugala,
Andrea Werner,
Laura Vitale,
Yi He
and other authors.
,
Rimas V. Lukas,
Lynn S. Ashby,
J. Paul Duic,
Maciej M. Mrugala,
Andrea Werner,
Laura Vitale,
Yi He
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 